-The Hindu Forest rights campaigners have slammed the satellite image-based study on the implementation of the Forest Rights Act (FRA) in Maharashtra as "deeply faulty and obviously biased," arguing that it manipulates data and facts to make a case against the Act. Countering the report which a private company prepared at the behest of the State Forest Department, a critique by Madhu Sarin and others of the Campaign for Survival and Dignity...

-Frontline The Land Acquisition Bill runs into a roadblock as political parties fail to reach an agreement on the substantive features of the draft Bill or on the amendments proposed. The efforts of the United Progressive Alliance government to broker a consensus on the Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Bill, 2012, which has been pending for over a year, have not paid off not because...

-The Indian Express Nagpur: A Maharashtra forest department study, based on GPS and satellite imagery, shows that "ineligible forest areas are being claimed and granted for land plots (pattas) under the Forest Rights Act." The FRA gives traditional forest dwellers the right over lands they had encroached for farming, subject to a cutoff of December 31, 2005. The implementing authority is the tribal affairs department, a sore point with the forest...

-Bloomberg The corpse of Indian farmer Bengali Singh burned to ash atop a blazing funeral pyre on the banks of the river Ganges in 2006. Five years later, the dead man was recorded as being paid by India's $33 billion rural jobs program to dig an irrigation canal in Jharkhand state. Officials in his village and the surrounding region used at least 500 identities, including those of Singh, a disabled child of...

-The Business Standard Court denies Swiss drug firm patent protection for its anti-cancer drug Glivec; domestic industry hails verdict The Supreme Court on Monday dismissed Novartis AG's appeal for patent protection of its anti-cancer drug, Glivec, putting an end to a seven-year battle between the Swiss drug maker, several domestic generic manufacturers, as well as patient groups fighting for affordable medicines. A Bench of judges Aftab Alam and Ranjana Desai said in a...